Dr. Tien-Li Lee is Aardvark's founder and has served as its Chief Executive Officer since March 2017. He has more than 20 years of experience as a biotechnology innovator and executive involved in founding or advancing several biopharmaceutical companies. Before founding Aardvark, he was Chief Strategy Officer of NantKwest, Inc. (Nasdaq: NK) from 2013 to 2017, Director of Business Development at Simcere Pharmaceutical Group from 2011 to 2013, and co-founder and Vice President of Business Development of Onkor Pharma from 2007 to 2011. He is an inventor or co-inventor of multiple biomedical innovations. Dr. Lee received his M.D. from the University of California, San Diego and his B.A. in Molecular Biology from the University of California, Berkeley, and completed post-graduate training at UCLA and UC Irvine.